Podcast: Unpacking FDA's Final Clinical Decision Support Guidance - Diagnosing Health Care

Epstein Becker & Green
Contact
The U.S. Food and Drug Administration (FDA) recently issued a final guidance document clarifying how the agency intends to regulate clinical decision support (CDS) software.

How has this document caused confusion for industry? How can companies respond?

On this episode, Epstein Becker Green attorneys Brad Thompson and Jessika Tuazon analyze the FDA’s latest CDS guidance and discuss the challenges industry faces as it attempts to make sense of, and comply with, that See more +

The U.S. Food and Drug Administration (FDA) recently issued a final guidance document clarifying how the agency intends to regulate clinical decision support (CDS) software.

How has this document caused confusion for industry? How can companies respond?

On this episode, Epstein Becker Green attorneys Brad Thompson and Jessika Tuazon analyze the FDA’s latest CDS guidance and discuss the challenges industry faces as it attempts to make sense of, and comply with, that guidance.

Visit our site for related reading links and more: http://www.ebglaw.com/dhc57

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces. Subscribe on your favorite podcast platform. See less -

Embed
Copy

Other MultiMedia by Epstein Becker & Green

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Epstein Becker & Green

Written by:

Epstein Becker & Green
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Epstein Becker & Green on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide